Year:2022   Volume: 4   Issue: 3   Area:

  1. Home
  2. Article List
  3. ID: 174

Hussain Ibrahim HUSSAIN, Ruqayah Ali SALMAN, Shaimaa S. MUTLAK


It is the most common cancer in the world, and in the United States it is the fifth most common. It is common for liver cancer patients to be diagnosed at an advanced stage, which has a negative impact on their prognosis. Hepatocellular carcinomas (HCCs) account for more than 90% of all liver cancer cases, and chemotherapy and immunotherapy are the most effective treatments. Patients with liver cancer need new therapeutic choices. It's possible that natural chemicals and/or nanotechnology can improve patient outcomes while minimizing negative effects. Improved treatment options can lead to better outcomes. This study concludes by highlighting a few of the challenges people with liver cancer face, as well as some promising new treatments.

Keywords: Hepatocellular Carcinoma, Alpha Fetoprotein, Molecular Tools, Protein And Non-Protein Tools, Apoptosis, Lysosomal Enzymes, Extracellular Matrix.